The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Negative Fluid-Attenuated Inversion Recovery- Based Intravenous Thrombolysis Using Recombinant Tissue Plasminogen Activator in Acute Stroke Patients with Unknown Onset Time
Open accessAbstract
Background: Approximately 25% of acute stroke patients were excluded from intravenous thrombolysis using recombinant tissue plasminogen activator (IV-tPA) because of unknown onset time. Recent studies have shown that patients with unknown onset time would be able to receive IV-tPA when showing no ischemia on fluid-attenuated inversion recovery (negative FLAIR). The present study evaluated the safety and feasibility of IV-tPA in patients with unknown onset time and negative FLAIR compared to those with standard IV-tPA. Methods: Stroke patients with unknown onset time were prospectively enrolled. Only patients with an occlusion of the internal carotid artery (ICA) and/or middle cerebral artery (M1 and M2) with a Diffusion-Weighted Imaging-Alberta Stroke Program Early CT Score (DWI-ASPECTS) ≥5 were analyzed. IV-tPA was performed within 3 h from the ‘first found abnormal time' if the patient showed negative FLAIR. Standard IV-tPA patients were extracted from our registry as controls after having been matched by age and occluded artery to the negative FLAIR (N-F) group. Results: Twenty patients in the N-F group and 60 in the control group were included. National Institutes of Health Stroke Scale (NIHSS) scores [median 18 (interquartile range 13-20) vs. 17 (12-20), p = 0.609] and DWI-ASPECTS [9 (7-9) vs. 8 (5-9), p = 0.213] were similar between the 2 groups. ICA occlusion was seen in 35%, M1 in 50%, and M2 in 15% in both groups. None of the N-F group and 1 (2%) of the control group experienced symptomatic intracerebral hemorrhage (p = 1.000). Recanalization within 1 h after IV-tPA was achieved in 6 (30%) patients in the N-F group and 24 (40%) in the control group (p = 0.595). Recanalization at 24 h after IV-tPA was seen in 13 (65%) patients in the N-F group and 43 (72%) in the control group (p = 0.584). At 7 days, 8 (40%) in the N-F group and 28 (47%) in the control group had a dramatic recovery (defined as a ≥10-point reduction in the total NIHSS score or a score of 0 or 1) (p = 0.796). At 3 months, a favorable outcome (modified Rankin scale score, 0-2) was seen in 47% in the N-F group and 33% in the control group (p = 0.365). Conclusion: IV-tPA in negative FLAIR patients with unknown onset time appears safe and feasible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684
Wahlgren, N., Ahmed, N., Dávalos, A., Ford, G. A., Grond, M., Hacke, W., Hennerici, M. G., Kaste, M., Kuelkens, S., Larrue, V., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60149-4 · Cited by 2,379
Saqqur, M., Uchino, K., Demchuk, A. M., Molina, C. A., Garami, Z., Calleja, S., Akhtar, N., Orouk, F. O., Salam, A., Shuaib, A., et al. (2007) · Stroke · doi:10.1161/01.str.0000257304.21967.ba · Cited by 688
Thomalla, G., Cheng, B., Ebinger, M., Hao, Q., Tourdias, T., Wu, O., Kim, J. S., Breuer, L., Singer, O. C., Warach, S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70192-2 · Cited by 602
Yamaguchi, T., Mori, E., Minematsu, K., Nakagawara, J., Hashi, K., Saito, I., & Shinohara, Y. (2006) · Stroke · doi:10.1161/01.str.0000227191.01792.e3 · Cited by 515
Rubiera, M., Ribo, M., Delgado-Mederos, R., Santamarina, E., Delgado, P., Montaner, J., Alvarez-Sabín, J., & Molina, C. A. (2006) · Stroke · doi:10.1161/01.str.0000237070.80133.1d · Cited by 421
Thomalla, G., Rossbach, P., Rosenkranz, M., Siemonsen, S., Krützelmann, A., Fiehler, J., & Gerloff, C. (2009) · Annals of Neurology · doi:10.1002/ana.21651 · Cited by 248
Population-based study of wake-up strokes
Mackey, J., Kleindorfer, D., Sucharew, H., Moomaw, C. J., Kissela, B. M., Alwell, K., Flaherty, M. L., Woo, D., Khatri, P., Adeoye, O., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318219fb30 · Cited by 242
Fink, J. N., Kumar, S., Horkan, C., Linfante, I., Selim, M. H., Caplan, L. R., & Schlaug, G. (2002) · Stroke · doi:10.1161/01.str.0000014585.17714.67 · Cited by 233
FLAIR can estimate the onset time in acute ischemic stroke patients
Aoki, J., Kimura, K., Iguchi, Y., Shibazaki, K., Sakai, K., & Iwanaga, T. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.03.011 · Cited by 158
Self-citationThrombolytic Therapy for Patients Who Wake-Up With Stroke
Barreto, A. D., Martin‐Schild, S., Hallevi, H., Morales, M. M., Abraham, A. T., Gonzales, N. R., Illoh, K., Grotta, J. C., & Savitz, S. I. (2009) · Stroke · doi:10.1161/strokeaha.108.528034 · Cited by 142
Calamante, F., Lythgoe, M. F., Pell, G. S., Thomas, D. L., King, M. D., Busza, A. L., Sotak, C. H., Williams, S. R., Ordidge, R. J., & Gadian, D. G. (1999) · Magnetic Resonance in Medicine · doi:10.1002/(sici)1522-2594(199903)41:3<479::aid-mrm9>3.0.co;2-2 · Cited by 140
Petkova, M. V., Rodrigo, S., Lamy, C., Oppenheim, G., Touzé, E., Mas, J., Méder, J.-F., & Oppenheim, C. (2010) · Radiology · doi:10.1148/radiol.10100461 · Cited by 130
Wake-Up Stroke: Clinical and Neuroimaging Characteristics
Silva, G. S., Lima, F. O., Camargo, E. C., et al. (2010) · Cerebrovascular Diseases · doi:10.1159/000278929 · Cited by 117
Mokin, M. V., Kass‐Hout, T., Kass‐Hout, O., Dumont, T. M., Kan, P. T. M., Snyder, K. V., Hopkins, L. N., Siddiqui, A. H., & Levy, E. I. (2012) · Stroke · doi:10.1161/strokeaha.112.655621 · Cited by 108
Safety and Efficacy of MRI-Based Thrombolysis in Unclear-Onset Stroke
Cho, A.-H., Sohn, S., Han, M., Lee, D. H., Kim, J. S., Choi, C. G., Sohn, C., Kwon, S. U., Suh, D. C., Kim, S. J., et al. (2008) · Cerebrovascular Diseases · doi:10.1159/000132204 · Cited by 97
Kimura, K., Iguchi, Y., Shibazaki, K., Watanabe, M., Iwanaga, T., & Aoki, J. (2009) · Stroke · doi:10.1161/strokeaha.109.552588 · Cited by 94
Self-citationPerkins, C. J., Kahya, E., Roque, C. T., Roche, P. E., & Newman, G. C. (2001) · Stroke · doi:10.1161/hs1201.099634 · Cited by 89
Early CT Findings in Unknown-Onset and Wake-Up Strokes
Todo, K., Moriwaki, H., Saito, K., et al. (2006) · Cerebrovascular Diseases · doi:10.1159/000091545 · Cited by 78
Moradiya, Y., & Janjua, N. A. (2012) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2012.07.016 · Cited by 74
Reperfusion Therapy in Unclear-Onset Stroke Based on MRI Evaluation (RESTORE)
Kang, D., Sohn, S., Hong, K., Yu, K., Hwang, Y., Han, M., Lee, J., Park, J., Cho, A., Kim, H., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.675926 · Cited by 70
Breuer, L., Schellinger, P. D., Huttner, H. B., Halwachs, R., Engelhorn, T., Doerfler, A., & Köhrmann, M. (2010) · International Journal of Stroke · doi:10.1111/j.1747-4949.2010.00410.x · Cited by 61
Cited by
Emberson, J., Lees, K. R., Lyden, P., Blackwell, L., Albers, G., Bluhmki, E., Brott, T., Cohen, G., Davis, S., Donnan, G., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60584-5 · Cited by 2,737
Treatment Strategies for Acute Ischemic Stroke Caused by Carotid Artery Occlusion
Li, W., Yin, Q., Xu, G., & Liu, X. (2016) · Interventional Neurology · doi:10.1159/000445304 · Cited by 2,319
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub3 · Cited by 1,370
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
Berge, E., Whiteley, W., Audebert, H., De Marchis, G., Fonseca, A. C., Padiglioni, C., Pérez de la Ossa, N., Strbian, D., Tsivgoulis, G., & Turc, G. (2021) · European Stroke Journal · doi:10.1177/2396987321989865 · Cited by 1,355
Wardlaw, J. M., Murray, V., Berge, E., del Zoppo, G., Sandercock, P., Lindley, R. L., & Cohen, G. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60738-7 · Cited by 1,010
Metadata
- Authors
- Aoki, J., Kimura, K., Shibazaki, K., & Sakamoto, Y.
- Venue
- Cerebrovascular Diseases Extra
- Publisher
- S. Karger AG
- Published
- 2013-03-23
- Volume
- 3
- Issue
- 1
- Pages
- 35-45
- ISSN
- 1664-5456 (ISSN-L)
- OpenAlex
- W2102447759
- Cited by
- 1,929
- References
- 23
- FWCI
- 95.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.